| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 121,666 | 100,563 | 71,019 | 76,561 | | Cost of Revenue | 93,692 | 80,010 | 65,193 | 67,420 | | | Gross Profit | 27,974 | 20,553 | 5,826 | 9,141 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 16,661 | 16,360 | 17,050 | 16,778 | | Non Recurring |
-
|
-
| 45,040 | 7,479 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 11,313 | 4,193 | (56,264) | (15,116) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 10,699 | 4,193 | (56,264) | (15,116) | | Interest Expense | (435) | 235 | 200 | 275 | | Income Before Tax | 11,134 | 3,958 | (56,464) | (15,391) | | Income Tax Expense | 3,945 | 1,402 | (19,762) | (6,181) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 7,189 | 2,556 | (36,702) | (9,210) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 7,189 | 2,556 | (36,702) | (9,210) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $7,189 | $2,556 | ($36,702) | ($9,210) |
|
0.02% Nasdaq 
0.33%
Income Statement
